Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event [Member]
1 Months Ended
Oct. 31, 2021
USD ($)
$ / shares
Subsequent Events (Details) [Line Items]  
Loan description the Company entered into a binding agreement with a subsidiary of Maruho Co. Ltd., or Maruho, a leading dermatology-focused pharmaceutical company in Japan, pursuant to which the Company issued to Maruho 375,000 shares of Common Stock at a price of $8.00 per share for gross proceeds of $3,000.
Securities Purchase Agreement [Member]  
Subsequent Events (Details) [Line Items]  
Sale of aggregate shares | shares 375,000
Warrants to purchase price per share | $ / shares $ 8
Gross proceeds | $ $ 3,000